Gene-Edited Brain Organoids Are Unlocking the Secrets of Autism
By Amit Katwala,
Wired
| 02. 21. 2022
Hundreds of genes have been linked to autism spectrum disorder (ASD), a complicated range of conditions affecting the behavior, social development, and communication of tens of millions people worldwide. But teasing out exactly what effect those genes have and how they relate to ASD has been devilishly difficult. “Nobody can study an actual human brain as it develops,” says Paola Arlotta, a professor of stem cell and regenerative biology at Harvard University. But a new approach based on growing clumps of brain cells in the lab is now yielding promising results.
Arlotta and her colleagues at Harvard and the Broad Institute of Harvard and MIT have been working with organoids—three-dimensional clumps of brain tissue grown from stem cells—usually just a few millimeters across. When organoids are left to grow, they start to develop different types of brain cells, and begin to organize into primitive networks that mimic some, but not all, of the architecture of the human brain.
Organoids grown from stem cells donated by people with ASD have been used to study the condition in the past. But...
Related Articles
Not the species, certainly, but the Institute of that name, which was founded by transhumanist philosopher Nick Bostrom in 2005 as a research group at Oxford University. According to a recently posted Final Report, its goal was “to pursue the big questions in a transdisciplinary way” by pulling together “researchers from disciplines such as philosophy, computer science, mathematics, and economics.” This evolved before long into the study and promotion of “effective altruism” and “longtermism” as...
By Tristan Manalac, BioSpace | 04.02.2024
Verve Therapeutics has suspended enrollment in the Phase Ib Heart-1 study evaluating its lead gene editing program VERVE-101 following a serious adverse event, the company announced Tuesday.
A patient, who received a 0.45-mg/kg dose of VERVE-101, developed a grade 3...
By Timnit Gebru and Émile P. Torres, First Monday | 04.14.2024
The stated goal of many organizations in the field of artificial intelligence (AI) is to develop artificial general intelligence (AGI), an imagined system with more intelligence than anything we have ever seen. Without seriously questioning whether such a system can...
By Harold Brubaker, The Philadelphia Inquirer | 04.04.2024
Acompany started by University of Pennsylvania scientist Jim Wilson has received FDA approval to test a form of gene editing in infants for the first time in the United States, the company said Thursday.
The Plymouth Meeting company, iECURE, is...